Abstract
Rationale
In critically ill patients receiving invasive mechanical ventilation (MV), research supports the use of daily screening to identify patients who are ready to undergo a spontaneous breathing trial (SBT) followed by conduct of an SBT. However, once daily (OD) screening is poorly aligned with the continuous care provided in most intensive care units (ICUs) and the best SBT technique for clinicians to use remains controversial.
Objectives
To identify the optimal screening frequency and SBT technique to wean critically ill adults in the ICU.
Methods
We aim to conduct a multicenter, factorial design randomized controlled trial with concealed allocation, comparing the effect of both screening frequency (once versus at least twice daily [ALTD]) and SBT technique (Pressure Support [PS] + Positive End-Expiratory Pressure [PEEP] vs T-piece) on the time to successful extubation (primary outcome) in 760 critically ill adults who are invasively ventilated for at least 24 h in 20 North American ICUs. In the OD arm, respiratory therapists (RTs) will screen study patients between 06:00 and 08:00 h. In the ALTD arm, patients will be screened at least twice daily between 06:00 and 08:00 h and between 13:00 and 15:00 h with additional screens permitted at the clinician’s discretion. When the SBT screen is passed, an SBT will be conducted using the assigned technique (PS + PEEP or T-piece). We will follow patients until successful extubation, death, ICU discharge, or until day 60 after randomization. We will contact patients or their surrogates six months after randomization to assess health-related quality of life and functional status.
Relevance
The around-the-clock availability of RTs in North American ICUs presents an important opportunity to identify the optimal SBT screening frequency and SBT technique to minimize patients’ exposure to invasive ventilation and ventilator-related complications.
Trial registration
Clinical Trials.gov, NCT02399267. Registered on Nov 21, 2016 first registered.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Rizvi, Leena 2 ; Cook, Deborah J. 3 ; Seely, Andrew J. E. 4 ; Rochwerg, Bram 5 ; Lamontagne, Francois 6 ; Devlin, John W. 7 ; Dodek, Peter 8 ; Mayette, Michael 6 ; Tanios, Maged 9 ; Gouskos, Audrey 10 ; Kay, Phyllis 10 ; Mitchell, Susan 10 ; Kiedrowski, Kenneth C. 10 ; Hill, Nicholas S. 11 1 University of Toronto, Interdepartmental Division of Critical Care, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); St Michael’s Hospital, Department of Medicine, Division of Critical Care Medicine, Toronto, Canada (GRID:grid.415502.7); St. Michael’s Hospital, Li Ka Shing Knowledge Institute, Toronto, Canada (GRID:grid.415502.7)
2 St Michael’s Hospital, Department of Medicine, Division of Critical Care Medicine, Toronto, Canada (GRID:grid.415502.7)
3 McMaster University, Department of Health Research Methods, Evidence and Impact, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227)
4 University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255)
5 McMaster University, Department of Health Research Methods, Evidence and Impact, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227); McMaster University, Department of Medicine, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227)
6 Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Canada (GRID:grid.411172.0) (ISNI:0000 0001 0081 2808)
7 Northeastern University, School of Pharmacy, Boston, USA (GRID:grid.261112.7) (ISNI:0000 0001 2173 3359); Tufts Medical Center, Division of Pulmonary, Critical Care and Sleep Medicine, Boston, USA (GRID:grid.67033.31) (ISNI:0000 0000 8934 4045)
8 Centre for Health Evaluation and Outcome Sciences, Vancouver, Canada (GRID:grid.498725.5); University of British Columbia, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830)
9 Longbeach Memorial, Critical Care Medicine, Longbeach, USA (GRID:grid.411172.0)
10 FAST – NAWC Trial, Patient and Family Advisory Committee Member, Toronto, Canada (GRID:grid.411172.0)
11 Tufts Medical Center, Division of Pulmonary, Critical Care and Sleep Medicine, Boston, USA (GRID:grid.67033.31) (ISNI:0000 0000 8934 4045)




